Campath and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Campath (alemtuzumab), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Tylenol, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Insomnia when taking Campath. It is created by eHealthMe based on reports of 4,897 people who have side effects when taking Campath from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,116 drugs and 5,173 conditions by eHealthMe. Check the latest studies of Insomnia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,897 people reported to have side effects when taking Campath.
Among them, 20 people (0.41%) have Insomnia.

Among these 20 people:

How long have people been on Campath when they have Insomnia? *

What is the gender of people who have Insomnia when taking Campath? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Insomnia when taking Campath? *

What are other drugs people take besides Campath? *

What are other side effects people have besides Insomnia? *

Thrombocytopenia (decrease of platelets in blood): 13 people, 65.00%
Weakness: 10 people, 50.00%
Neuropathy Peripheral (surface nerve damage): 10 people, 50.00%
Fatigue (feeling of tiredness): 8 people, 40.00%
Hypotension (abnormally low blood pressure): 8 people, 40.00%
Dizziness: 8 people, 40.00%
Rashes (redness): 7 people, 35.00%
Infection: 7 people, 35.00%
Nausea (feeling of having an urge to vomit): 7 people, 35.00%
Abdominal Pain: 6 people, 30.00%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 30.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 15.00%
Neoplasm Malignant (cancer tumour): 3 people, 15.00%
High Blood Cholesterol: 3 people, 15.00%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 15.00%
Pain: 2 people, 10.00%
Itching: 1 person, 5.00%
Diabetes: 1 person, 5.00%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 5.00%
Immunodeficiency Disorders: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Campath:

Campath (4,909 reports)

Insomnia treatments and more:

Insomnia (438,087 reports)

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,116 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,173 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab (the active ingredients of Campath) and Campath (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.